|
|
MarketView
Events defining the day's trading activity on Wall Street
Lauren Rudd
Monday, May 12, 2014
Summary
It was an interesting day on Wall Street on Monday
with both the Dow Jones Industrial Average and the S&P 500 indexes
closing out the day at record highs, while the Nasdaq rallied as shares
of Internet and biotech shares advanced. The Dow chalked up a record
closing high and an intraday record high of 16,704. Biogen Idec was up 4.8 percent to $300.54 and
TripAdvisor Inc gained 5.8 percent to close at $89.51. Twitter was up
5.9 percent to $33.94 after news reports that SunTrust raised its rating
on the stock to a "buy." These momentum shares have been wildly volatile in
recent sessions after a sharp selloff that began in March on concerns
about their high valuations. The Russell 2000 index of small-cap stocks climbed
2.4 percent, its largest daily percentage gain since early March. At its
session low Friday, the index was down exactly 10 percent from the
intraday record high set in early March. A correction, which is a drop
of 10 percent from a recent high, is often seen as a harbinger of more
weakness. The rally came despite a vote by pro-Russian rebels
in favor of self-rule in eastern regions of the country in a referendum
dismissed by Kiev and Western governments as illegal. The European Union
is set to step up pressure on Russia by taking steps to extend sanctions
to companies, as well as individuals. Hillshire Brands announced that it had agreed to
acquire Pinnacle Foods in a deal valued at about $6.6 billion, including
debt. Pinnacle ended the day up 13.2 percent to close at $34.47, while
Hillshire fell 3.2 percent to end the day at $35.76. U.S.-listed shares of Indian companies and
India-related exchange-traded funds also rose as exit polls in India
predicted that the country's main opposition party - viewed as more
business friendly - would win general elections. In the latest development on deals in the healthcare
sector, shares of Allergan fell one percent to $159.72 after the
company, known for Botox, its popular anti-wrinkle treatment, rejected
Valeant Pharmaceuticals takeover offer of $47 billion. Valeant's
U.S.-listed shares slipped 0.8 percent to $130.16. Tesaro was up 21 percent to $29.05 after the company
said its experimental drug to prevent chemotherapy-induced nausea and
vomiting met the main goal in a third late-stage trial. Approximately 5.7 billion shares changed hands on
the major equity exchanges, a number that was below the 6.2 billion
share average for the month to date, according to data from BATS Global
Markets.
Government Posts Reduced Deficit for April The United States posted a $107 billion budget
surplus in April, according to Treasury Department figures released on
Monday, suggesting the federal government was on track to slash its
annual deficit. Washington usually runs a surplus in April because
households have a deadline for settling tax bills that month. Tax receipts have are up sharply this year as the
economy has improved. The Congressional Budget Office expects the
deficit will shrink to $492 billion during the fiscal year, which began
in October. In 2013, the government ran a $680 billion deficit. So far this year, the government has run $306
billion into the red. That deficit is 37 percent smaller than it was in
the same period of fiscal 2013. Last month's receipts were $8 billion
higher than they were in April of last year. Outlays were also higher,
though they have been on a downward trend in part because an improved
labor market has led fewer people to draw on jobless benefits. The
expiration of benefits for many long-term unemployed workers in January
has also reduced outlays.
|
|
|
MarketView for May 12
MarketView for Monday, May 12